Your browser doesn't support javascript.
loading
More attention for high-risk pathological features for stage Ⅱ colorectal cancer required / 中华病理学杂志
Chinese Journal of Pathology ; (12): 773-777, 2023.
Artículo en Chino | WPRIM | ID: wpr-1012306
ABSTRACT
Stage Ⅱ (T3-4N0M0) accounts for 25% of colorectal cancer and five-year survival is between 70% and 80%. However, 25% of patients develop distant metastases and have a survival rate similar to that of stage Ⅲ disease. However, whether or not to give adjuvant chemotherapy is still a controversial issue. As a result, there has been a lot of interest in the identification of the pathological factors underlying the poor prognosis associated with this stage, in order to establish a firmer basis for the administration of adjuvant chemotherapy. But not all high-risk factors are equal for stage Ⅱ colorectal cancer, variability still exists in the management and outcomes of high-risk patients. Here be introduced and commented on thinking and understanding about its controversy and evolution for the attention of the working pathologist and gastroenterologist doctors.
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Pronóstico / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Factores de Riesgo / Quimioterapia Adyuvante / Estadificación de Neoplasias Límite: Humanos Idioma: Chino Revista: Chinese Journal of Pathology Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Pronóstico / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Factores de Riesgo / Quimioterapia Adyuvante / Estadificación de Neoplasias Límite: Humanos Idioma: Chino Revista: Chinese Journal of Pathology Año: 2023 Tipo del documento: Artículo